rs150236371

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005045.4(RELN):​c.7438G>A​(p.Gly2480Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00303 in 1,614,086 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0023 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 5 hom. )

Consequence

RELN
NM_005045.4 missense

Scores

6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:6

Conservation

PhyloP100: 4.75

Publications

10 publications found
Variant links:
Genes affected
RELN (HGNC:9957): (reelin) This gene encodes a large secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. This protein may be involved in schizophrenia, autism, bipolar disorder, major depression and in migration defects associated with temporal lobe epilepsy. Mutations of this gene are associated with autosomal recessive lissencephaly with cerebellar hypoplasia. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
RELN Gene-Disease associations (from GenCC):
  • lissencephaly with cerebellar hypoplasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Norman-Roberts syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P, PanelApp Australia
  • familial temporal lobe epilepsy 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant epilepsy with auditory features
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ankylosing spondylitis
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.019006014).
BP6
Variant 7-103523443-C-T is Benign according to our data. Variant chr7-103523443-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 95229.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00231 (351/152234) while in subpopulation NFE AF = 0.00341 (232/68034). AF 95% confidence interval is 0.00305. There are 2 homozygotes in GnomAd4. There are 161 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RELNNM_005045.4 linkc.7438G>A p.Gly2480Ser missense_variant Exon 47 of 65 ENST00000428762.6 NP_005036.2
RELNNM_173054.3 linkc.7438G>A p.Gly2480Ser missense_variant Exon 47 of 64 NP_774959.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RELNENST00000428762.6 linkc.7438G>A p.Gly2480Ser missense_variant Exon 47 of 65 5 NM_005045.4 ENSP00000392423.1

Frequencies

GnomAD3 genomes
AF:
0.00231
AC:
351
AN:
152116
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00979
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00292
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00341
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00257
AC:
647
AN:
251476
AF XY:
0.00255
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.00962
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00351
Gnomad NFE exome
AF:
0.00317
Gnomad OTH exome
AF:
0.00228
GnomAD4 exome
AF:
0.00310
AC:
4534
AN:
1461852
Hom.:
5
Cov.:
31
AF XY:
0.00314
AC XY:
2285
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33478
American (AMR)
AF:
0.000984
AC:
44
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00957
AC:
250
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00277
AC:
239
AN:
86254
European-Finnish (FIN)
AF:
0.00294
AC:
157
AN:
53420
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00325
AC:
3616
AN:
1111978
Other (OTH)
AF:
0.00348
AC:
210
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
239
478
718
957
1196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
142
284
426
568
710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00231
AC:
351
AN:
152234
Hom.:
2
Cov.:
32
AF XY:
0.00216
AC XY:
161
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.000481
AC:
20
AN:
41542
American (AMR)
AF:
0.00118
AC:
18
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00979
AC:
34
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00229
AC:
11
AN:
4814
European-Finnish (FIN)
AF:
0.00292
AC:
31
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00341
AC:
232
AN:
68034
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00297
Hom.:
2
Bravo
AF:
0.00196
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00363
AC:
14
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00291
AC:
25
ExAC
AF:
0.00241
AC:
293
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00349
EpiControl
AF:
0.00338

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Jun 18, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RELN: BS2

Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 08, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24828792, 14515139, 30949922)

not specified Uncertain:1Benign:1
Nov 11, 2016
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 28, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Norman-Roberts syndrome Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Intellectual disability Benign:1
Jan 01, 2019
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.11
T;.;.
Eigen
Benign
0.17
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.88
D;D;D
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.019
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
N;N;.
PhyloP100
4.8
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.7
N;N;N
REVEL
Benign
0.19
Sift
Benign
0.25
T;T;T
Sift4G
Uncertain
0.036
D;D;D
Vest4
0.43
ClinPred
0.019
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.21
gMVP
0.74
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150236371; hg19: chr7-103163890; COSMIC: COSV58989457; COSMIC: COSV58989457; API